rs761714818

Variant summary

Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PM2PM5PP3_StrongPP5_Very_Strong

The NM_021971.4(GMPPB):ā€‹c.656T>Cā€‹(p.Ile219Thr) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000874 in 1,613,790 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (ā˜…ā˜…). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. I219F) has been classified as Likely pathogenic.

Frequency

Genomes: š‘“ 0.000046 ( 0 hom., cov: 33)
Exomes š‘“: 0.000092 ( 0 hom. )

Consequence

GMPPB
NM_021971.4 missense

Scores

10
8
1

Clinical Significance

Pathogenic/Likely pathogenic criteria provided, multiple submitters, no conflicts P:7

Conservation

PhyloP100: 9.06
Variant links:
Genes affected
GMPPB (HGNC:22932): (GDP-mannose pyrophosphorylase B) This gene is thought to encode a GDP-mannose pyrophosphorylase. The encoded protein catalyzes the conversion of mannose-1-phosphate and GTP to GDP-mannose, a reaction involved in the production of N-linked oligosaccharides. Alternatively spliced transcript variants encoding distinct isoforms have been described. [provided by RefSeq, Jan 2009]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Pathogenic. Variant got 16 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PM5
Other missense variant is known to change same aminoacid residue: Variant chr3-49722344-T-A is described in ClinVar as [Likely_pathogenic]. Clinvar id is 1180706.Status of the report is criteria_provided_single_submitter, 1 stars.
PP3
MetaRNN computational evidence supports a deleterious effect, 0.955
PP5
Variant 3-49722343-A-G is Pathogenic according to our data. Variant chr3-49722343-A-G is described in ClinVar as [Likely_pathogenic]. Clinvar id is 575991.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr3-49722343-A-G is described in Lovd as [Likely_pathogenic]. Variant chr3-49722343-A-G is described in Lovd as [Pathogenic].

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
GMPPBNM_021971.4 linkuse as main transcriptc.656T>C p.Ile219Thr missense_variant 7/9 ENST00000308388.7
GMPPBNM_013334.4 linkuse as main transcriptc.656T>C p.Ile219Thr missense_variant 7/8

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
GMPPBENST00000308388.7 linkuse as main transcriptc.656T>C p.Ile219Thr missense_variant 7/91 NM_021971.4 P1Q9Y5P6-1

Frequencies

GnomAD3 genomes
AF:
0.0000460
AC:
7
AN:
152160
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0000483
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000735
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000637
AC:
16
AN:
251086
Hom.:
0
AF XY:
0.0000737
AC XY:
10
AN XY:
135706
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.0000327
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000132
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.0000917
AC:
134
AN:
1461630
Hom.:
0
Cov.:
43
AF XY:
0.0000880
AC XY:
64
AN XY:
727116
show subpopulations
Gnomad4 AFR exome
AF:
0.0000597
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000116
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.000108
Gnomad4 OTH exome
AF:
0.000182
GnomAD4 genome
AF:
0.0000460
AC:
7
AN:
152160
Hom.:
0
Cov.:
33
AF XY:
0.0000538
AC XY:
4
AN XY:
74334
show subpopulations
Gnomad4 AFR
AF:
0.0000483
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.0000735
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.0000659
Hom.:
0
Bravo
AF:
0.0000793
ExAC
AF:
0.0000741
AC:
9
EpiCase
AF:
0.0000545
EpiControl
AF:
0.0000593

ClinVar

Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Pathogenic:3
Pathogenic, criteria provided, single submitterclinical testingGeneDxFeb 24, 2023Published functional studies demonstrate a damaging effect with decreased enzymatic activity as compared to wild type (Liu et al., 2021); Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 24780531, 26133662, 30684953, 26310427, 30257713, 34758253, 35006422) -
Likely pathogenic, criteria provided, single submitterclinical testingRevvity Omics, RevvitySep 21, 2020- -
Pathogenic, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenJul 01, 2024GMPPB: PM3:Very Strong, PM2, PP1, PS3:Supporting -
GMPPB-related disorder Pathogenic:1
Likely pathogenic, criteria provided, single submitterclinical testingWomen's Health and Genetics/Laboratory Corporation of America, LabCorpMar 13, 2023Variant summary: GMPPB c.656T>C (p.Ile219Thr) results in a non-conservative amino acid change located in the Nucleotidyl transferase domain (IPR005835) of the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 6.4e-05 in 251086 control chromosomes. This frequency does not allow conclusions about variant significance. c.656T>C has been reported in the literature as a compound heterzygous genotype in individuals affected with features of GMPPB-Related Disorders such as alpha-dystroglycanopathy, congenital muscular dystrophy, brain abnormalities and generalized epilepsy (example, PMID: 26133662, 26310427, 35006422, 24780531, 28688748). These data indicate that the variant is likely to be associated with disease. At least one publication reports experimental evidence evaluating an impact on protein function (example, PMID: 35006422). The most pronounced variant effect results in 40% of normal GDP-mannose pyrophosphorylase B (GMPPB) activity in-vitro. Four clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. All laboratories classified the variant as pathogenic/likely pathogenic. Based on the evidence outlined above, the variant was classified as likely pathogenic. -
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A14 Pathogenic:1
Likely pathogenic, no assertion criteria providedclinical testingGenomics England Pilot Project, Genomics England-- -
Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A14;C3809221:Muscular dystrophy-dystroglycanopathy (congenital with intellectual disability), type B14;C4518000:Autosomal recessive limb-girdle muscular dystrophy type 2T Pathogenic:1
Pathogenic, criteria provided, single submitterclinical testingInvitaeDec 10, 2023This sequence change replaces isoleucine, which is neutral and non-polar, with threonine, which is neutral and polar, at codon 219 of the GMPPB protein (p.Ile219Thr). This variant is present in population databases (rs761714818, gnomAD 0.01%). This missense change has been observed in individuals with alpha-dystroglycanopathy and congenital muscular dystrophy (PMID: 24780531, 26133662, 26310427; Invitae). It has also been observed to segregate with disease in related individuals. ClinVar contains an entry for this variant (Variation ID: 575991). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt GMPPB protein function with a negative predictive value of 80%. For these reasons, this variant has been classified as Pathogenic. -
Abnormality of the musculature Pathogenic:1
Likely pathogenic, criteria provided, single submitterclinical testingKariminejad - Najmabadi Pathology & Genetics CenterJul 10, 2021- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.58
BayesDel_addAF
Pathogenic
0.36
D
BayesDel_noAF
Pathogenic
0.51
CADD
Uncertain
25
DANN
Uncertain
1.0
DEOGEN2
Pathogenic
0.83
D;.;D
Eigen
Uncertain
0.25
Eigen_PC
Uncertain
0.36
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Pathogenic
1.0
.;D;D
M_CAP
Pathogenic
0.69
D
MetaRNN
Pathogenic
0.95
D;D;D
MetaSVM
Uncertain
0.61
D
MutationAssessor
Uncertain
2.1
M;M;M
MutationTaster
Benign
1.0
D;D;D;D
PrimateAI
Uncertain
0.77
T
PROVEAN
Uncertain
-3.5
D;D;D
REVEL
Pathogenic
0.96
Sift
Pathogenic
0.0
D;D;D
Sift4G
Uncertain
0.0020
D;D;D
Polyphen
0.27
B;B;B
Vest4
0.96
MutPred
0.82
Loss of stability (P = 0.042);Loss of stability (P = 0.042);Loss of stability (P = 0.042);
MVP
0.90
MPC
0.73
ClinPred
0.36
T
GERP RS
4.8
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.91
gMVP
0.92

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs761714818; hg19: chr3-49759776; API